MapLight Therapeutics (MPLT) Retained Earnings (2024 - 2025)
MapLight Therapeutics (MPLT) reported Retained Earnings of -$228000.0 for Q4 2025, down 239.88% on a YoY basis from $163000.0 in Q4 2024, and up 99.92% sequentially from -$281.0 million in Q3 2025.
MapLight Therapeutics (MPLT) Retained Earnings (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Retained Earnings data on file, last reported at -$228000.0 in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 239.88% year-over-year to -$228000.0; the trailing twelve-month figure through Dec 2025 stood at -$228000.0 (down 239.88% YoY), and the FY2025 full-year result was -$228000.0, down 239.88% from the prior year.
- Retained Earnings grew to -$228000.0 in Q4 2025, from -$281.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $163000.0 in Q4 2024 to a low of -$281.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | MapLight Therapeutics | 305.82 Mn | 305.82 Mn | - | -228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -228,000.00 |
| Sep 30, 2025 | -281.00 Mn |
| Dec 31, 2024 | 163,000.00 |